healthtech
about 2 hours agoSaudi Arabia's Biotech Strategy, H.E. Dr. Bandar Al-Knawy Explains
Saudi Arabia is executing a National Biotechnology Strategy to build vaccines, biomanufacturing and genomics capabilities, anchored by institutional partnerships led by Dr. Bandar Al‑Knawy and a KAIMRC–Flagship Pioneering pact backed by an initial $70M to enable early‑phase clinical trials.